2017
DOI: 10.18632/oncotarget.20642
|View full text |Cite|
|
Sign up to set email alerts
|

Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6

Abstract: Copyright: Golob-Schwarzl et al. This is an open-access article distributed under the terms of the Creative Commons AttributionLicense 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACTColorectal cancer (CRC) is the third most common cause of cancer related death worldwide. Furthermore, with more than 1.2 million cases registered per year, it constitutes the third most frequent diagnosed cancer entity wor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
54
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 39 publications
(60 citation statements)
references
References 36 publications
6
54
0
Order By: Relevance
“…45,46 It is overexpressed in multiple tumor types, 47,48 including CRC, where expression of EIF6 has been shown to increase from normal colon, through adenoma to CRC. 45,46 It is overexpressed in multiple tumor types, 47,48 including CRC, where expression of EIF6 has been shown to increase from normal colon, through adenoma to CRC.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…45,46 It is overexpressed in multiple tumor types, 47,48 including CRC, where expression of EIF6 has been shown to increase from normal colon, through adenoma to CRC. 45,46 It is overexpressed in multiple tumor types, 47,48 including CRC, where expression of EIF6 has been shown to increase from normal colon, through adenoma to CRC.…”
Section: Discussionmentioning
confidence: 99%
“…EIF6 is a translation initiation factor that plays a role in ribosome complex formation and protein synthesis downstream of PI3K/Akt/mTOR signaling pathway. 45,46 It is overexpressed in multiple tumor types, 47,48 including CRC, where expression of EIF6 has been shown to increase from normal colon, through adenoma to CRC. 49 Functional studies on EIF6 suggest its oncogenic activity through increasing cancer cell motility and invasion.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, the PI3K/AKT/mTOR signaling activity is related with an upregulation of eIF3B [ 121 ]. Golob-Schwarzl and colleagues showed the expression of eIFs family members, bringing eIF1, eIF5, and eIF6 to attention, together with components of the PI3K/AKT/mTOR signaling cascade in colorectal cancer (CRC) [ 122 ]. These eIF subunits and the PI3K/AKT/mTOR signaling members had a significant influence on the overall survival of CRC patients [ 122 ].…”
Section: Eifs and Pi3k/akt/mtor Pathwaymentioning
confidence: 99%
“…mTOR regulates the assembly of eIF4f to manage translation initiation. The PI3K/AKT/mTOR pathway affects tumorigenesis through eIFs, reported in HCC [ 119 ], GC [ 121 ], CRC [ 122 ], and other cancer types [ 117 , 134 ]. In summary, eIFs integrate the signals from the PI3K/AKT/mTOR pathway, which may be a promising target for tumor therapy in future.…”
Section: Challenges and Future Directionsmentioning
confidence: 99%
“…In recent years, the role of eukaryotic translation initiation factors (eIFs) in carcinogenesis has been steadily uncovered [15][16][17]. They are involved in tumour development, progression and invasion.…”
Section: Introductionmentioning
confidence: 99%